Abstract
I should like to propose that a new drug ought to be introduced into clinical practice in two stages. The first step in the case of enflurane has been taken by this congress and the second may be taken after the next ten years, when we shall probably be familiar with all the side effects of enflurane, and finally capable of an adequate use of the drug.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1974 Springer Verlag Berlin Heidelberg
About this paper
Cite this paper
Wåhlin, Å. (1974). Concluding Remarks. In: Lawin, P., Beer, R., Wiethoff, E. (eds) Ēthrane. Anaesthesiology and Resuscitation / Anaesthesiologie und Wiederbelebung / Anesthésiologie et Réanimation, vol 84. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65931-7_24
Download citation
DOI: https://doi.org/10.1007/978-3-642-65931-7_24
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-06877-8
Online ISBN: 978-3-642-65931-7
eBook Packages: Springer Book Archive